ESC 365 - Do novel lipid-lowering drugs improve cardiovascular outcomes in patients with type 2 diabetes?

ESC Professional Premium Access

Do novel lipid-lowering drugs improve cardiovascular outcomes in patients with type 2 diabetes?

Session: Improving cardiorenal outcomes in type 2 diabetes

Topic: Diabetes and the Heart

Speaker: Doctor M. Lettino (Monza, IT)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Maddalena Lettino

IRCCS San Gerardo of Tintori Foundation, Monza (Italy)

36 presentations

0 follower

4 more presentations in this session

Can lifestyle impact outcomes in type 2 diabetes and heart failure?

Speaker: Professor A. Abreu (Lisbon, PT)

Do novel antidiabetic drugs improve cardiorenal outcomes in patients with type 2 diabetes?

Speaker: Professor C. Wanner (Wuerzburg, DE)

Are newer-generation stents as good as CABG in type 2 diabetes?

Speaker: Professor M. Roffi (Geneva, CH)

Improving cardiorenal outcomes in type 2 diabetes - discussion

Access the full session

Improving cardiorenal outcomes in type 2 diabetes

Speakers: Doctor M. Lettino, Professor A. Abreu, Professor C. Wanner, Professor M. Roffi

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources